Donati Marcello, Stavrou Gregor A, Stang Axel, Basile Francesco, Oldhafer Karl J
Department of Surgery & Medical-Surgical Specialties, General & Oncologic Surgery Unit, Vittorio-Emanuele University Hospital, University of Catania, 95122 Catania, Italy.
Future Oncol. 2015;11(8):1233-43. doi: 10.2217/fon.14.316.
The liver-first approach was proposed for the first time in 2006 to obtain resectability of stage IV colorectal cancer patients and complete the therapeutic plan. From then some groups have used this new revolutionary approach reporting promising results. Other alternative strategies have been proposed for metastatic patients. The authors reviewed the literature weighing the pros and cons of each strategy proposed to manage these advanced tumor stages. The therapeutic options are analyzed in the light of oncologic problems and evidence. Also problems, questions and perspectives are given. Even if the 'liver-first' approach seems to be a promising strategy, the ideal diagnostic-therapeutic flowchart for metastatic colorectal cancer is still difficult to standardize. The great heterogeneity of this population of patients is one of the main problems. A 'tailored approach' philosophy is necessary to calibrate, in a multidisciplinary setting, a case-by-case choice of therapeutic options.
2006年首次提出了“肝优先”方法,以实现IV期结直肠癌患者的可切除性并完成治疗计划。从那时起,一些研究团队采用了这种全新的革命性方法,并报告了令人鼓舞的结果。针对转移性患者,也提出了其他替代策略。作者回顾了文献,权衡了为管理这些晚期肿瘤阶段而提出的每种策略的利弊。根据肿瘤学问题和证据对治疗选择进行了分析。同时也给出了问题、疑问和前景。即使“肝优先”方法似乎是一种很有前景的策略,但转移性结直肠癌的理想诊断-治疗流程图仍难以标准化。这类患者的巨大异质性是主要问题之一。在多学科背景下,需要采用“个性化方法”理念,根据具体情况逐一选择治疗方案。